Therapy (HCV)
Time Factor And RNA Levels Predict Sustained Response
Published in Hepatitis Weekly, March 19th, 2001
Physicians frequently look for viral clearance at the end of therapy to determine sustained response after interferon (IFN) monotherapy or interferon/ribavirin combination therapy for HCV patients. However, the best determinant for predicting sustained response to either therapy, according to researchers at the University of Alcala de Henares School of Medicine in Spain, is to measure viral levels at patient-specific time intervals.
J.L. Calleja and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-03-19)
More Articles from Hepatitis Weekly
- Therapy (HCV)
Non-Responders To Interferon Profit From Adding Ribavirin To Regimen - Autoimmune Hepatitis
Cholangiography Best For Differentiating Sclerosing Cholangitis From AIH - Pathogenesis
Hepatitis C Virus Clamps Onto Protein Synthesis Machinery - At-Risk Populations
Injection Drug Users At Needle Exchange Program Share Few Syringes, And Those Who Do Share With Friends - Hepatic Steatosis
Obesity And Liver Fibrosis Common To Chinese HCV Patients With Fatty Liver - Hepatocellular Carcinoma
Careful Evaluation Should Precede Adoption Of Surveillance Programs - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
